- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Compensated Cirrhosis in Italy
Total 115 results
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
Solvay PharmaceuticalsTerminatedAcute Decompensated Heart Failure; Renal DysfunctionUnited States, Canada, Chile, Denmark, France, Germany, Italy, Poland, Romania, Russian Federation, Ukraine
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Bulgaria, Canada, Czechia, France, Greece, Hungary, Ireland, Israel, Italy, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom, Vietnam
-
Gilead SciencesTerminatedHepatitis C Virus InfectionFrance, Spain, United States, Australia, Canada, Germany, United Kingdom, Italy, New Zealand, Puerto Rico
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Spain, France, Canada, Germany, Italy, Puerto Rico, United Kingdom, Belgium
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
Galmed Research and Development, Ltd.Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaboratorsCompletedLiver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver FibrosesUnited States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
AstraZenecaCompletedNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France